Studies connect hormone to breast cancer and uncover potential for novel targeted drugs
2021-04-26
(Press-News.org) The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey Cancer Center finds strong evidence that prolactin also acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease.
Hormones have proteins on their cell surface called receptors that receive and send biological messages and regulate cell function. Through research published in npj Breast Cancer, VCU Massey Cancer Center researcher Charles Clevenger, M.D., Ph.D., and his lab discovered a new, altered form of the prolactin receptor called the human prolactin receptor intermediate isoform (hPRLrI) that directly drives breast cancer. The researchers observed that this modified version of the prolactin receptor interacted with other forms of the receptor to turn benign breast cells into malignant ones, and the presence of hPRLrI in breast cancer cells was associated with triple negative breast cancer, a rapid rate of cell reproduction and poor outcomes.
"This research challenges the dogma that prolactin only functions in milk production and highlights the unique discovery that the hormone can contribute to breast cancer," said Clevenger, who is the associate director for precision oncology, Carolyn Wingate Hyde Endowed Chair in Cancer Research and member of the Cancer Biology research program at Massey as well as chair of the Department of Pathology at the VCU School of Medicine. "By understanding how the prolactin receptor correlates to breast cancer, novel therapeutic and prognostic agents can be developed to effectively treat the disease."
Clevenger said these findings support the argument that future approaches in drug design may need to specifically target hPRLrI, and could ultimately inform advanced diagnostic applications for breast cancer as well.
Through a separate study published in Endocrinology and prominently showcased on the journal's website as the Featured Article for a week, Clevenger's lab substantially prevented tumor growth in preclinical models of ER-positive breast cancer using an HDAC6 inhibitor, a drug that blocks a protein associated with prolactin.
Clevenger has previously found success in the lab stunting breast cancer growth by deactivating Stat5, the genetic pathway responsible for the production of prolactin.
In this new research, the scientists found that the prolactin-regulating function of Stat5 is dually dependent on the enzyme histone deacetylase-6 (HDAC6) and the gene HMGN2. They also discovered that the estrogen receptor (ER), a hormone widely believed to influence breast cancer development, was highly and almost exclusively interactive with Stat5 at sites where HDAC6 and HMGN2 were also present. This suggests that both the estrogen receptor and prolactin receptor can cooperate through the activation of Stat5 to initiate the development of breast cancer. Treating ER-positive breast cancer cells with an HDAC6 inhibitor drastically hindered tumor progression.
"Global analysis of gene expression again revealed that prolactin is closely associated with breast cancer growth and could be subdued by treatment with an HDAC6 inhibitor," Clevenger said.
Clevenger has dedicated a significant amount of his scientific career to understanding how prolactin might have implications in the growth and progression of breast tumors. In future studies, he plans to further test and develop breast cancer drugs using prolactin as a primary target.
INFORMATION:
Clevenger collaborated on the npj Breast Cancer study with Chuck Harrell, Ph.D., member of the Cancer Biology research program at VCU Massey Cancer Center; Michael Idowu, M.P.H., M.B.B.S., Massey research member; Jacqueline Grible, Ph.D., Shannon Hedrick, Patricija Zot, M.D., and Alicia Woock, of the VCU School of Medicine; and Amy Olex, M.S., of the VCU C. Kenneth and Dianne Wright Center for Clinical and Translational Research.
Clevenger collaborated on the Endocrinology study with Harrell, Justin Craig and Tia Turner from the VCU School of Medicine.
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2021-04-26
One in five pharmacies refuse to dispense a key medication to treat addiction, according to new research.
The study, published in the journal Drug and Alcohol Dependence, was conducted by researchers at Oregon Health & Science University and the Oregon State University College of Pharmacy. Researchers called hundreds of pharmacies around the country to ask whether they would dispense Suboxone, also known as buprenorphine.
"Buprenorphine is a vital, lifesaving medication for people with opioid use disorder, but improving access has been a problem for a variety of reasons," said senior author Daniel Hartung, Pharm.D., M.P.H., professor in the College of Pharmacy. "Although anecdotes and smaller studies have suggested problems, our study is the first to systematically characterize this ...
2021-04-26
A partnership between UC Davis and Maurice J. Gallagher, Jr., chairman and CEO of Allegiant Travel Company, has led to a new rapid COVID-19 test.
A recent study published Nature Scientific Reports shows the novel method to be 98.3% accurate for positive COVID-19 tests and 96% for negative tests.
"This test was made from the ground up," said Nam Tran, lead author for the study and a professor of pathology in the UC Davis School of Medicine. "Nothing like this test ever existed. We were starting with a clean slate."
The novel COVID-19 test uses an analytical instrument known as a mass spectrometer, which is paired with a powerful machine-learning platform to detect SARS-CoV-2 in nasal swabs. The mass spectrometer can analyze samples in minutes, with the ...
2021-04-26
PULLMAN, Wash. - Climate problems alone were not enough to end periods of ancient Pueblo development in the southwestern United States.
Drought is often blamed for the periodic disruptions of these Pueblo societies, but in a study with potential implications for the modern world, archaeologists have found evidence that slowly accumulating social tension likely played a substantial role in three dramatic upheavals in Pueblo development.
The findings, detailed in an article in the Proceedings of the National Academy of Sciences, showed that Pueblo farmers often persevered through droughts, but when social tensions were increasing, even modest droughts could spell the end of an era of ...
2021-04-26
The risk of childhood undernutrition varies widely among villages in India, according to new research led by Harvard T.H. Chan School of Public Health in collaboration with researchers at Harvard's Center for Geographic Analysis, Harvard's Center for Population and Development Studies, Korea University, Microsoft, and the Government of India.
The study is the first to predict and map the burden of childhood undernutrition across all of the nearly 600,000 villages in rural India, and the methods developed to do so could be applied to other health indicators and help advance the field of "precision public health," in which interventions and policies are tailored to smaller populations that are disproportionally ...
2021-04-26
One of the great mysteries of modern space science is neatly summed up by the view from NASA's Perseverance, which just landed on Mars: Today it's a desert planet, and yet the rover is sitting right next to an ancient river delta.
The apparent contradiction has puzzled scientists for decades, especially because at the same time that Mars had flowing rivers, it was getting less than a third as much sunshine as we enjoy today on Earth.
But a new study led by University of Chicago planetary scientist Edwin Kite, an assistant professor of geophysical sciences and an expert on climates of other worlds, uses a computer model to put forth a promising explanation: Mars ...
2021-04-26
Understanding spoken words, developing normal speech - cochlear implants enable people with profound hearing impairment to gain a great deal in terms of quality of life. However, background noises are problematic, they significantly compromise the comprehension of speech of people with cochlear implants. The team led by Tobias Moser from the Institute for Auditory Neuroscience and InnerEarLab at the University Medical Center Göttingen and from the Auditory Neuroscience and Optogenetics Laboratory at the German Primate Center - Leibniz Institute for Primate Research (DPZ) is therefore working to improve cochlear implants. The scientists want to use genetic engineering methods to make the nerve cells in the ear ...
2021-04-26
MADISON, Wis. -- In October of 2020, Jennifer Doudna and Emmanuelle Charpentier were awarded the Nobel Prize in chemistry for their discovery of an adaptable, easy way to edit genomes, known as CRISPR, which has transformed the world of genetic engineering.
CRISPR has been used to fight lung cancer and correct the mutation responsible for sickle cell anemia in stem cells. But the technology was also used by a Chinese scientist to secretly and illegally edit the genomes of twin girls -- the first-ever heritable mutation of the human germline made with genetic engineering.
"We've moved away from an era of science where we understood the risks that came with new technology and where decision stakes were ...
2021-04-26
New findings detailing the world's first-of-its-kind estimate of how many people live in high-altitude regions, will provide insight into future research of human physiology.
Dr. Joshua Tremblay, a postdoctoral fellow in UBC Okanagan's School of Health and Exercise Sciences, has released updated population estimates of how many people in the world live at a high altitude.
Historically the estimated number of people living at these elevations has varied widely. That's partially, he explains, because the definition of "high altitude" does not have a fixed cut-off.
Using novel techniques, Dr. Tremblay's publication in the Proceedings of the National ...
2021-04-26
New research reveals a genetic quirk in a small species of songbird in addition to its ability to carry a tune. It turns out the zebra finch is a surprisingly healthy bird.
A study published today in the journal Proceedings of the National Academy of Sciences reveals that zebra finches and other songbirds have a low-density lipoprotein receptor (LDLR) gene surprisingly different than other vertebrates.
The function of LDLR, which is responsible for cellular uptake of LDL-bound cholesterol, or "bad cholesterol," has been thought to be conserved across vertebrates. OHSU scientists found that in the case ...
2021-04-26
Stomata, formed by a pair of kidney-shaped guard cells, are tiny pores in leaves. They act like mouths that plants use to "eat" and "breathe." When they open, carbon dioxide (CO2) enters the plant for photosynthesis and oxygen (O2) is released into the atmosphere. At the same time as gases pass in and out, a great deal of water also evaporates through the same pores by way of transpiration.
These "mouths" close in response to environmental stimuli such as high CO2 levels, ozone, drought and microbe invasion. The protein responsible for closing these "mouths" is an anion channel, called SLAC1, which moves negatively charged ions across the guard cell membrane to reduce turgor pressure. Low pressure causes the guard cells to collapse and subsequently the stomatal pore to ...
LAST 30 PRESS RELEASES:
[Press-News.org] Studies connect hormone to breast cancer and uncover potential for novel targeted drugs
